CMO/CDMO Biotechnology Market Trend, CAGR Status, Growth, Analysis and Forecast 2021-2031
The global CMO/CDMO biotechnology market is set to be valued at US$ 9.1 Bn in 2021. The market for CMO/CDMO biotechnology is estimated to rise at a CAGR of around 11%, with estimated sales of close to US$ 28 Bn in 2031. Leading CDMOs are focusing on expanding manufacturing capabilities with single-use technologies that can ramp up production and shift toward one-stop CSOs that have integrated capabilities to develop molecule to finished products.
Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/32516
A contract development and manufacturing CDMO provides development and manufacturing services to biotechnology/biopharmaceuticals companies. Pharma/biopharma and biotechnology companies partners with CDMOs as a way to outsource drug development and drug manufacturing.
Development services, bio manufacturing services, analytical testing, fill finishing, packaging, and clinical supply services are some of the services provided by biotechnology CDMOs/CMOs.
With advancements in contract solutions, leading CDMOs are focusing on the expansion of their integrated capabilities from molecule-to-finished product. The trend is significant as the acceleration of development and the market is becoming more crucial for biopharmaceutical and biologics developers.
Leading industry players are focusing on the development and launch of next-generation bio therapeutics to treat serious life-threatening diseases. The current biologics-development pipeline supports an outlook of continued healthy growth. The number of biotech patents applied for every year has been growing at approximately 23% annually.
• Patheon NV
• Samsung Biologics Co., Ltd
• Boehringer Ingelheim
• Samsung BioLogics
• AGC Biologics, Inc.
• Avid Bioservices, Inc.
• Fujifilm Diosynth Biotechnologies
• Xpress Biologic
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/32516
Key Takeaways from Market Study
• Standalone services hold around 57% value share, globally, primarily due to growing cell-line development services by biopharmaceutical and biotechnology companies.
• Leading global CDMOs are focusing on expansion of their manufacturing capabilities with high flexibility and rapid operation. With the help of advanced single-use technologies, companies are able to cut batch manufacturing and cleaning time from 7 days to 1 day.
• In terms of product, monoclonal antibodies are leading the market and are expected to hold 47% market share over the forecast period. This is owing to significant success rate of development and approval of both, bio-specific and antibody fragments.
• The mammalian segment widely dominates at 80% share, owing to the capabilities to add human-like post-translational modifications to complex protein therapeutics.
• By company size, mid-size contract development manufacturers accounted for the largest share of global CDMO/CMO biotechnology manufacturing. This is mainly because most of small operation CMOs have capabilities to produce enough antibodies.
• Based on scale of operation, the commercial segment is leading with 50% market share, owing to increasing approvals of new bio therapeutics and their commercialization.
• The region of North America is dominant in the global market for CMO/CDMO biotechnology, and will continue to remain the most lucrative market over the forecast period.
"Growing outsourcing to CMO/CDMOs and for monoclonal antibodies (mAbs), and technological upgrades to boost manufacturing are expected to drive the market over the coming years" says an analyst of Persistence Market Research.
New Product Launches - Strategy by Key Players
Key manufacturers of CMO/CDMO biotechnology use the strategy of introducing new and innovative solutions. Moreover, they also focus on expanding their market with collaborations and acquisitions in key regions. This factor induces intense competition among market players.
• For instance, in Oct 2018, Boehringer Ingelheim achieved a next-expansion milestone in biologics production in the U. S. The company invested €200 million. This expansion has increased the company's worldwide capacity for manufacturing biopharmaceutical medicines, which exceeds 290,000 liters.
What Does the Report Cover?
Persistence Market Research offers a unique perspective and actionable insights on the CMO/CDMO biotechnology market in its latest study, presenting historical demand assessment of 2016 - 2020 and projections for 2021 - 2031.
The research study is based on service (standalone services and integrated development), product (monoclonal antibodies, antibody fragments, recombinant therapeutic proteins, viral vector, cell and gene therapy, and vaccines), platform/ expression system (mammalian, microbial, insect and others), company/ organization size (small, mid-sized, large, and very large), and scale of operation/application (preclinical, clinical, commercial, and others), across seven key regions of the world.
Access Full Report@ https://www.persistencemarketresearch.com/market-research/cmo-cdmo-biotechnology-market.asp
Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - firstname.lastname@example.org
Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release CMO/CDMO Biotechnology Market Trend, CAGR Status, Growth, Analysis and Forecast 2021-2031 here
News-ID: 2745995 • Views: 90
More Releases from Persistence Market Research
Architectural LED Products Market Unit Sales to Witness Significant Growth in th …
LED products are comparatively more environment-friendly than other lighting solutions. This benefit has positively impacted market growth over the past years. LED products are energy-efficient, which helps reduce the load on electricity power plants. Besides, LED lights have focused light that helps reduce unwanted light pollution in the environment, which is otherwise caused due to scattered light from other traditional lighting products. LED products also emit negligible heat, as they have
The Optical Transceivers Market To Take A Diligently Innovative Turn
Transceiver is a device that performs both transmission and reception of signals with a common circuitry over a network. An optical transceiver, also called as fiber optic transmitter and receiver, completes the operation of transmission by converting the electrical signal in light pulse and vice versa at the receiving end. In case of fiber optics, the information is sent in the form of light pulses. The light pulses need to
Global Europe Sporting Goods Market to Witness Rapid Growth in Demand During 202 …
The Europe sporting goods market is currently worth US$ 171.9 Bn, and is predicted to expand at a CAGR of 7.7% from 2022 to 2031. Increasing focus on health and fitness is a major trend that is prevalent across the world, and is hugely popular across Europe, which will propel the sales of sporting goods in the region. There has been substantial increase in the instances of obesity due to
Antioxidants Market 2022 Industry Key Players, Trend, Analysis and Forecast to 2 …
Antioxidants Market 2022 The global antioxidants market is anticipated to register growth at a value CAGR of 6.6% and top a of US$ 1.8 Bn by 2031. Major utilization of antioxidants is for providing added shelf-life solutions for meat, poultry, and seafood processing industries. Ever-growing meat consumption is creating opportunities for manufacturers of antioxidants to offer their products as a potent ingredient for ensuring shelf-life stability to end processed products. Request For
More Releases for CDMO
Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Trends …
The industrial research report on ‘Contract Research Organization (CRO) and CDMO for Pharmaceutical Market’ offers in depth analysis on the crucial factors like market share, size, growth factors, drivers, and challenges. The report delivers actionable insights on these factors to help the business players, manufacturers, and marketing executives to plan operational strategies for the forecast period 2020 - 2025. Market Growth Insights Reports also studies the market from 360 degree perspective to
CDMO Market Size, Share, Trends, Analysis and Forecast 2020-2026
The global market for healthcare CDMO is projected to have considerable CAGR of around 7.6% during the forecast period. The major factor that driving the global healthcare CDMO market is the rising adoption of the outsourcing services by the pharmaceutical and biotechnology companies across the globe. Additionally, outsourcing the manufacturing in the pharmaceutical industry provide the companies to deviate workforce to other processing tasks which as a result makes monetary
Contract Research Organization (CRO) and CDMO for Pharmaceutical Market- Growth, …
The Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Report 2020 is a professional and in-depth study on the current state of the Contract Research Organization (CRO) and CDMO for Pharmaceutical Market. This report focuses on Contract Research Organization (CRO) and CDMO for Pharmaceutical volume and value at global level, regional level and company level. From a global perspective, this report represents overall Contract Research Organization (CRO) and CDMO
Global CMO/CDMO Market Production, Valuation and Sales Forecast 2019-2025 | Reci …
The report on the Global CMO/CDMO Market is prepared to help the stakeholders get a better perspective of the prevailing trends impacting its growth. The study provides in-depth knowledge of the Global CMO/CDMO Market, covering the impact of various regulations and policies adopted by the leading market players. The key drivers of the market, restrains, and trends influencing the Global CMO/CDMO Market are assessed through qualitative and quantitative investigation. The
Pharmaceutical CDMO Services Market | AMRI Global, Recipharm AB, Patheon N.V., C …
Global Pharmaceutical CDMO Services Market: Overview The demand within the global market for pharmaceutical CDMO services has been rising on account of the need develop safe and effective drugs for the treatment of multiple diseases and disorders. Contract Development and Manufacturing Organisations (CDMO) are offshoots of the pharmaceutical industry that help pharmaceutical companies in manufacturing, research, and development of drugs and other pharmaceutical products. CDMO provides key services such as research
CMO/CDMO Market Overview and Scope 2019 to 2025 | Kay Players Like Recipharm, AM …
Researchmoz added Most up-to-date research on "CMO/CDMO Market Overview and Scope 2019 to 2025 | Kay Players Like Recipharm, AMRI3, Patheon, Aenova and Catalent" to its huge collection of research reports. CMO/CDMO Market report includes (6 Year Forecast 2019-2025) includes Overview, classification, industry value, price, cost and gross profit. It also offers in-intensity insight of the CMO/CDMO industry masking all vital parameters along with, Drivers, Market Trends, Market Dynamics, Opportunities, Competitive